Radboud University Nijmegen Medical Centre-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Radboud University Nijmegen Medical Centre - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013407
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Radboud University Nijmegen Medical Centre (Radboud UMC), a subsidiary of Radboud University is a university medical center that offers patient care, research, and scientific training services. The centre’s patient care services include basic care, tertiary care, top referral care, and transmural care. It offers university courses in medicine, dentistry, biomedical sciences, molecular life, nursing and paramedical courses. Radboud UMC’s research fields include oncology, infection, inflammation and immunity, genetic and metabolic disease, neuroscience, molecular life sciences and evidence based medicine. The centre operates in Nijmegen, Eindhoven and Oss. Radboud UMC is headquartered in Nijmegen, the Netherlands.

Radboud University Nijmegen Medical Centre – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Radboud University Nijmegen Medical Centre, Medical Devices Deals, 2011 to YTD 2017 9
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Khondrion Enters into Collaboration Agreement with Nijmegen Center for Mitochondrial Disorders 11
Okklo Life Sciences Enters Into Agreement with Radboud University Nijmegen 12
TcLand Expression Enters Into Co-Development Agreement With Radboud University Nijmegen 13
Licensing Agreements 14
ProQR Therapeutics Enters into Licensing Agreement with Radboud University Medical Center 14
Radboud University Nijmegen Medical Centre – Key Competitors 15
Radboud University Nijmegen Medical Centre – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Research And Development 17
Sep 30, 2016: Netherlands Public-Private Partnership to Launch Comprehensive, Observational Study of Parkinson’s Disease 17
Government and Public Interest 18
Jul 19, 2016: Seventeen Veni grants for Radboud researchers, two for Max Planck 18
May 17, 2016: Vidi grant for eight Radboud researchers 21
Apr 11, 2016: Rubicon grants for six researchers 23
Jan 07, 2016: Radboud researchers receive over €6 million in European funding 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Key Facts 2
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Radboud University Nijmegen Medical Centre, Deals By Therapy Area, 2011 to YTD 2017 8
Radboud University Nijmegen Medical Centre, Medical Devices Deals, 2011 to YTD 2017 9
Radboud University Nijmegen Medical Centre, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Khondrion Enters into Collaboration Agreement with Nijmegen Center for Mitochondrial Disorders 11
Okklo Life Sciences Enters Into Agreement with Radboud University Nijmegen 12
TcLand Expression Enters Into Co-Development Agreement With Radboud University Nijmegen 13
ProQR Therapeutics Enters into Licensing Agreement with Radboud University Medical Center 14
Radboud University Nijmegen Medical Centre, Key Competitors 15
Radboud University Nijmegen Medical Centre, Subsidiaries 16

★海外企業調査レポート[Radboud University Nijmegen Medical Centre-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • J.B. Hunt Transport Services, Inc.:企業の戦略・SWOT・財務情報
    J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary J.B. Hunt Transport Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Ausgrid:企業の戦略的SWOT分析
    Ausgrid - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Feldan Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Feldan Bio Inc (Feldan) is a biotechnology company. It discovers, develops, manufactures and markets research therapeutic and industrial protein products. The company offers cell therapy products, genome editing products and research products. Its genome editing product includes recombinant …
  • Nestle Purina PetCare Company:企業の戦略・SWOT・財務情報
    Nestle Purina PetCare Company - Strategy, SWOT and Corporate Finance Report Summary Nestle Purina PetCare Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Astaldi Spa:企業の戦略・SWOT・財務分析
    Astaldi Spa - Strategy, SWOT and Corporate Finance Report Summary Astaldi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expression …
  • Allscripts Healthcare Solutions, Inc.:企業の戦略・SWOT・財務分析
    Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Allscripts Healthcare Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Mott MacDonald Group Ltd:企業の戦略的SWOT分析
    Mott MacDonald Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Enmax Corp:企業の戦略的SWOT分析
    Enmax Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Strikeforce Technologies Inc (SFOR):企業の財務・戦略的SWOT分析
    Summary Strikeforce Technologies Inc (Strikeforce) is a technology company that offers cybersecurity solutions. The company offers products such as protectID, guardedID and mobiletrust. Strikeforce offers services such as information technology services, key logging and mobile security solutions, am …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vietnam Golf Tourism JSC:企業の戦略・SWOT・財務情報
    Vietnam Golf Tourism JSC - Strategy, SWOT and Corporate Finance Report Summary Vietnam Golf Tourism JSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Erste Group Bank AG:企業の戦略・SWOT・財務分析
    Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report Summary Erste Group Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vedanta Ltd:企業のM&A・事業提携・投資動向
    Vedanta Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vedanta Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Alps Electric Co., Ltd.:企業の戦略・SWOT・財務情報
    Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Eureka Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Eureka Therapeutics Inc (Eureka Therapeutics) which focuses on the development of novel T cell immunotherapies for the treatment of solid tumors. Its pipeline encompasses drug candidates for various indications such as liver cancer, hematological cancer, lung cancer, head and cervical cancer …
  • Medrobotics Corp:製品パイプライン分析
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)-医療機器分野:企業M&A・提携分析
    Summary Jiangsu Yuyue Medical Equipment & Supply Co Ltd (Jiangsu Yuyue) is a medical device company that manufactures and distributes various medical equipments. The company’s products include electronic blood pressure monitor, air sterilization purifier, X-ray machine, blood glucose meter, temperat …
  • Bruker Daltonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bruker Daltonics Inc (Bruker Daltonics), a subsidiary of Bruker Corp, is a medical device company that manufactures scientific instruments for molecular and materials research, and for industrial and applied analysis. The company's products include mass spectrometry and separations, preclini …
  • Anchiano Therapeutics Ltd (BICL):製薬・医療:M&Aディール及び事業提携情報
    Summary Anchiano Therapeutics Ltd (Anchiano) formerly BioCancell Ltd, focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancer-related diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company's produc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆